SHOULDER & ELBOW
AAOS2019: Assessing the impact of celecoxib on tendon healing after arthroscopic rotator cuff repair
79 patients scheduled for an arthroscopic rotator cuff repair were randomized to receive pre- and postoperative celecoxib or placebo for 3 weeks. The outcome of interest was healing rate, and follow up was performed at 1 year. The findings from the study found no significant differences in healing rate between the celecoxib and placebo groups, despite a difference in healing rate of 19.4%. Readers should note that only 39% of patients were available for analysis at 1 year.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
